Article info
Young Investigators Oral Presentations (ENYGO Session)
Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?
Citation
Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?
Publication history
- First published November 1, 2019.
Online issue publication
March 03, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.